Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Zentiva Pharma UK Limited, One Onslow Street, Guildford, Surrey, GU1 4YS, United Kingdom Trading as: Zentiva, One Onslow Street, Guildford, Surrey, GU1 4YS, UK
Ciprofibrate 100mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White to off white round tablets with a breakline on one side and embossed ‘S170’ on the other. |
Each tablet contains 100mg ciprofibrate as the active ingredient.
For excipients, see 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ciprofibrate |
Ciprofibrate is a new derivative of phenoxyisobutyric acid which has a marked hypolipidaemic action. It reduces both LDL and VLDL and hence the levels of triglyceride and cholesterol associated with these lipoprotein fractions. It also increases levels of HDL cholesterol. |
| List of Excipients |
|---|
|
Maize starch |
Clear PVC/Aluminium blister strips in packs of 28 tablets.
Amber glass bottles of 100 tablets.
Not all pack sizes may be marketed.
Zentiva Pharma UK Limited, One Onslow Street, Guildford, Surrey, GU1 4YS, United Kingdom
Trading as: Zentiva, One Onslow Street, Guildford, Surrey, GU1 4YS, UK
PL 17780/0456
18 June 2009
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
